Folate is associated with the natural history of high-risk human papillomaviruses

Cancer Research

Volumn 64, Issue 23, 2004, Pages 8788-8793

  Piyathilake, Chandrika J ^a   Henao, Olga L ^a   Macaluso, Maurizio ^a   Cornwell, Phillip E ^a   Meleth, Sreelatha ^a   Heimburger, Douglas C ^a   Partridge, Edward E ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CAROTENE; CYANOCOBALAMIN; FOLIC ACID; RETINOL; TRACE ELEMENT;

ADULT; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CERVICAL CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG MECHANISM; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; NUTRIENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 9244231821     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2402     Document Type: Article

References (42)

1. Muir CS. Epidemiology, basic science, and the prevention of cancer: implications for the future. Cancer Res 1990;50:6441-8.
2. WHO. Cytological screening of cervical cancer: technical guidelines. Geneva: WHO; 1988.
3. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA - Cancer J Clin 2001;51:15-36.
4. Ponten J, Guo Z. Precancer of the Human cervix. In: Fund ICR, editor. Cancer surveys: precancer: biology, importance and possible prevention. Imperial Cancer Res Fund 1998;32:201-29.
5. Wright TC. Invasive cervical cancer and cervical intraepithelial lesions in women infected with the human immunodeficiency virus. Clin Consul Obstet Gynecol 1994;6:11.
6. Sadeghi SB, Sadeghi AM, Robboy S. Prevalence of dysplasia and cancer of the cervix in a nationwide: planned parenthood population. Cancer (Phila.) 1988;61:2359-61,
7. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (Bethesda) 1993;85:958-64.
8. Bosch FX, Munoz N, Shah KV, et al. Second international workshop on the epidemiology of cervical cancer and human papillomavirus. Int J Cancer 1992;52:171-3.
9. Munger K. The role of human papillomaviruses in human cancers. Front Biosci 2002;7:641-9.
10. IARC monographs on the evaluation of carcinogenic risks to humans. In: Human papillomaviruses. Vol. 64: Lyon, France: International Agency for Research on Cancer; 1995.
11. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous inlraepithelial lesion development in young females. J Am Med Assoc 2001;285:2995-3002.
12. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
13. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.
14. Liaw K, Glass AG, Manos MM, et al. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst (Bethesda) 1999;91:954-60.
15. Wallin KL, Wiklund F, Angstrom T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-8.
16. Ylitalo N, Sørensen P, Josefsson AM, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2194-8.
17. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
18. Xi LF, Carter JJ, Galloway DA, et al. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomark Prev 2002;11:343-51.
19. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (Bethesda) 1995;87:1365-71.
20. Romney SL, Ho GY, Palan PR, et al. Effects of beta-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol Oncol 1997;65:483-92.
21. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. J Am Med Assoc 2001;286:3106-14.
22. Maiman M, Fruchter RG. Cervical neoplasia and the human immunodeficiency virus: In: Rubin SC, Hoskins WJ, editors. Cervical cancer and preinvasive neoplasia. Philadelphia: Lippincott-Raven 1996:405-16.
23. Chandra S, Chandra RK. Nutrition, immune response, and outcome. Prog Food Nutr Sc 1986;10:165.
24. Dhur A, Galan P, Hercberg S. Folate status and the immune system. Prog Food Nutr Sc 1991;15:43-60.
25. Sedjo RL, Papenfuss MR, Craft NE, Giuliano AR. Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States). Cancer Causes Control 2003;14:319-26.
26. Giuliano AR, Papenfuss M, Nour M, Canfield LM, Schneider A, Hatch K. Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomark Prev 1997;6:917-23.
27. Sedjo RL, Inserra P, Abrahamsen M, et al. Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomark Prev 2002;11:353-9.
28. Sedjo RL, Fowler BM, Schneider A, Henning SM, Hatch K, Giuliano AR. Folate, vitamin B12, and homocysteine status, findings of no relation between human papillomavirus persistence and cervical dysplasia. Nutrition 2003;19:497-502.
29. Palan PR, Chang CJ, Mikhail MS, Ho GY, Basu J, Romney SL. Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions. Nutr Cancer 1998;30:46-52.
30. Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 2000;44:726-42.
31. Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL. Local and systemic effects of cigarette smoking on folate and vitamin B12. Am J Clin Nutr 1994;60:559-66.
32. Piyathilake CJ. Folate and vitamin B-12 status and chromosomal damage in the buccal mucosa of smokers and non-smokers [dissertation]. Birmingham, AL: University of Alabama at Birmingham; 1993.
33. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW. FRA3B extends over a broad region and contains a spontaneous HPV 16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 1996;5:187-95.
34. Popescu NC, DiPaolo JA, Amsbaugh SC. Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 1987;44:58-62.
35. Piyathilake CJ, Henao OL, Meleth S, Partridge E, Heimburger D. Folate is associated with the acquisition, persistence and clearance of high-risk (HR) human papillomavirus (HPV). FASEB J 2003;17:A373.
36. Cullen AP, Reid R, Campion M, Lorincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991;65:606-12.
37. Nagao S, Yoshinouchi M, Miyagi Y, Hongo A, Kodama J, Itoh S, Kudo T. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J Clin Microbiol 2002;40:863-7.
38. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40:886-91.
39. Chan PK, Chang AR, Cheung JL, et al. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis 2002;185:28-35.
40. Ho GY, Kadish AS, Burk RD, et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 1998;78:281-5.
41. Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomark Prev 1995;4:415-28.
42. Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortification. Lancet 1999;354:915-6.